RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Luis M. Vilá to Treatment Outcome

This is a "connection" page, showing publications Luis M. Vilá has written about Treatment Outcome.
Connection Strength

0.987
  1. Medina-Cintr?n N, Mart?nez I, P?rez-R?os N, Berr?os-L?pez Y, Vil? LM. Clinical Manifestations and Outcomes in Disease-Modifying Antirheumatic Drug-Naive Adult Patients with Chronic Chikungunya Arthritis. Am J Trop Med Hyg. 2021 03 08; 104(5):1741-1746.
    View in: PubMed
    Score: 0.126
  2. V?zquez-Sanabria IL, Vil? LM. Sustained Improvement of Fibromyalgia Syndrome After Electroconvulsive Therapy for Intractable Depression. J Clin Rheumatol. 2016 Aug; 22(5):289-90.
    View in: PubMed
    Score: 0.092
  3. Varela-Rosario N, P?rez-Berenguer JL, Vil? LM. Efficacy of immunosuppressive treatment in a systemic lupus erythematosus patient presenting with inclusion body myositis. BMJ Case Rep. 2016 Apr 05; 2016.
    View in: PubMed
    Score: 0.090
  4. V?zquez-Sanabria IL, Mercado-Seda R, Varela-Rosario N, Vil? LM. Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome. BMJ Case Rep. 2015 Jul 22; 2015.
    View in: PubMed
    Score: 0.085
  5. Arroyo-?vila M, Vil? LM. Cardiac tamponade in a patient with mixed connective tissue disease. J Clin Rheumatol. 2015 Jan; 21(1):42-5.
    View in: PubMed
    Score: 0.082
  6. Font YM, Castro-Santana LE, Nieves-Plaza M, Maldonado M, Mayor AM, Vil? LM. Factors associated with regional rheumatic pain disorders in a population of Puerto Ricans with diabetes mellitus. Clin Rheumatol. 2014 Jul; 33(7):995-1000.
    View in: PubMed
    Score: 0.077
  7. Rodr?guez-P?rez N, Rodr?guez-Navedo Y, Font YM, Vil? LM. Inflammatory myopathy as the initial presentation of cryoglobulinaemic vasculitis. BMJ Case Rep. 2013 Jun 03; 2013.
    View in: PubMed
    Score: 0.074
  8. Santiago-Casas Y, Gonz?lez-Rivera T, Castro-Santana L, R?os G, Mart?nez D, Rodr?guez V, Gonz?lez-Alcover R, Mayor AM, Vil? LM. Impact of managed care health insurance system for indigent patients with rheumatoid arthritis in Puerto Rico. Clin Rheumatol. 2013 Jun; 32(6):763-9.
    View in: PubMed
    Score: 0.072
  9. Castro-Santana LE, Col?n M, Molina MJ, Rodr?guez VE, Mayor AM, Vil? LM. Efficacy of two cyclophosphamide regimens for the treatment of lupus nephritis in Puerto Ricans: low vs. standard dose. Ethn Dis. 2010; 20(1 Suppl 1):S1-116-21.
    View in: PubMed
    Score: 0.058
  10. Santiago-Casas Y, Gonz?lez-Rivera TC, Castro-Santana LE, R?os G, Mart?nez D, Rodr?guez VE, Gonz?lez-Alcover R, Mayor AM, Vil? LM. Impact of age on clinical manifestations and outcome in Puerto Ricans with rheumatoid arthritis. Ethn Dis. 2010; 20(1 Suppl 1):S1-191-5.
    View in: PubMed
    Score: 0.058
  11. Vil? LM, Alarc?n GS, McGwin G, Friedman AW, Baethge BA, Bastian HM, Fessler BJ, Reveille JD. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford). 2004 Mar; 43(3):358-63.
    View in: PubMed
    Score: 0.038
  12. Amaral JK, Bingham CO, Taylor PC, Vil? LM, Weinblatt ME, Schoen RT. Therapy for Chikungunya Arthritis: A Study of 133 Brazilian Patients. Am J Trop Med Hyg. 2023 09 06; 109(3):542-547.
    View in: PubMed
    Score: 0.037
  13. Vil? LM, Mayor AM, Valent?n AH, Garc?a-Soberal M, Vil? S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus. 2000; 9(2):110-5.
    View in: PubMed
    Score: 0.029
  14. Vil? LM, Mayor AM, Valent?n AH, Rodr?guez SI, Reyes ML, Acosta E, Vil? S. Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. P R Health Sci J. 1999 Jun; 18(2):89-94.
    View in: PubMed
    Score: 0.028
  15. Willis R, Seif AM, McGwin G, Martinez-Martinez LA, Gonz?lez EB, Doan E, Dang N, Papalardo E, Liu J, Vil? LM, Reveille JD, Alarc?n GS, Pierangeli SS. Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort. Clin Exp Rheumatol. 2014 Mar-Apr; 32(2):162-7.
    View in: PubMed
    Score: 0.019
  16. Dur?n-Barrag?n S, McGwin G, Vil? LM, Reveille JD, Alarc?n GS. Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort. Rheumatology (Oxford). 2008 Jul; 47(7):1093-6.
    View in: PubMed
    Score: 0.013
  17. Mart?nez A, Vil? LM, R?os-Olivares E. Predominance of CD4+ T cells and Th2 cytokines in the pericardial fluid of a dermatomyositis patient with cardiac tamponade. Clin Exp Rheumatol. 2004 Jan-Feb; 22(1):135.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support